Pfizer

Pfizer, others will have to conduct clinical trials of COVID-19 vaccine in India for approval

Pfizer and BioNTech will have to conduct local clinical trials for securing emergency use authorisation for its COVID-19 vaccine, the government has said. The head of the government task force on COVID-19 vaccine, Dr. VK Paul, said that local clinical trials are a pre-condition for seeking emergency use authorisation. Notably, Pfizer and BioNTech have applied...

WHO clears Pfizer’s COVID-19 vaccine

At a time when the majority of the countries in the world are yet to approve a vaccine for COVID-19, the World Health Organisation (WHO) has given its nod to the jab developed by Pfizer and BioNTech. The development essentially means that low-income countries may soon get access to the ‘costly’ vaccine that is already...

India likely to approve AstraZeneca-Oxford COVID-19 vaccine by next week

India is likely to grant emergency use authorisation for the vaccine jointly developed by AstraZeneca and University of Oxford by next week, media reports suggest. The vaccine that was recently in controversy over efficacy data is being manufactured by Pune-based Serum Institute of India (SII). If granted emergency use permission, India could be the first...

Healthcare worker in Alaska suffers allergic reaction after taking Pfizer’s COVID-19 vaccine

In a major cause of concern over the safety and efficacy of the COVID-19 vaccine that has been granted emergency use authorisation by the authorities, an Alaskan healthcare worker who was administered Pfizer and BioNTech’s COVID-19 vaccine suffered a serious allergic reaction. The affected person is stable now after availing treatment for the allergic reaction....

DCGI seeks more data from Serum Institute, Bharat Biotech for approving their COVID vaccines

The government regulator dealing with the emergency use authorisation (EUA) application of COVID-19 vaccine manufacturers has clarified that the Serum Institute of India and Bharat Biotech will have to submit more data for securing EUA in India. The Subject Experts Committee (SEC) on EUA is of the view that it is better to wait for...

SII applies for govt approval for AstraZeneca-Oxford COVID vaccine

Adar Poonawalla-led Serum Institute of India has become the first Indian company to apply for emergency use authorisation (EUA) for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford. The development comes on the heels of US-based vaccine giant Pfizer’s Indian arm approaching the Drugs Controller General of India (DCGI) for EUA for...

UK grants approval to Pfizer’s COVID-19 vaccine, vaccination to start next week

US-based vaccine maker Pfizer and its German partner BioNTech on Wednesday announced that they have secured emergency use authorisation for their COVID-19 vaccine in the UK. The development has made the UK one of the first countries to start immunisation of its population, as early as next week, against the deadly virus that has affected...

Pfizer to seek approval for its COVID-19 vaccine, claims it is 95% effective

Pfizer and BioNTech on Wednesday announced that after conducting the final efficacy analysis in their ongoing Phase 3 study, their COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% in participants without prior SARS-CoV-2 infection and also in participants with and...

India in talks with Moderna after its COVID-19 vaccine shows efficacy of 94.5%

With COVID-19 cases, as well as deaths, increasing with each passing day, a vaccine against the deadly virus seems to be the only solution to contain the pandemic. While there are several vaccine candidates that are at various stages of clinical trials, some of them have shown promising results with an efficacy of over 90...